Evaluating the relative treatment efficacy of CD40 agonist mitazalimab in combination with mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) using unanchored indirect treatment comparisons (ITCs) Meeting Abstract
| Authors: | O'Reilly, E. M.; Macarulla, T.; Dahan, L.; Borbath, I.; Cassier, P. A.; Guelfucci, F.; Ngami, A.; Pico de CoanĖa, Y.; Wainberg, Z. A.; Ambarkhane, S. V.; Van Laethem, J. L. |
| Abstract Title: | Evaluating the relative treatment efficacy of CD40 agonist mitazalimab in combination with mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) using unanchored indirect treatment comparisons (ITCs) |
| Meeting Title: | 2025 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2025 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-01 |
| DOI: | 10.1200/JCO.2025.43.4_suppl.723 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PUBMED: | 37988030 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 723 -- Source: CINAHL Plus with Full Text |
